Phase 1 Study of Neural Stem Cells & 5-FC/Leucovorin for the Treatment of Recurrent High Grade Gliomas

神经干细胞的一期研究

基本信息

项目摘要

DESCRIPTION (provided by applicant): Human neural stem cells (NSCs), modified to express a therapeutic transgene, may hold promise for brain tumor therapy due to their inherent tumor-tropic properties and potential use as vehicles for delivering chemotherapy directly to infiltrating glioma cells in the brain. NSCs ca overcome obstacles of drug-delivery that limit current gene therapy strategies to provide an effective anti-tumor response. Data from animal models have demonstrated the safety and efficacy of NSCs for tracking to invasive tumor cells as well as to distant micro-tumor foci and delivering therapeutic gene products to tumor cells. The investigators have recently completed a first-in-human pilot study of cytosine deaminase (CD)-expressing NSCs given in combination with oral 5-fluorocytosine (5-FC), demonstrating that one dose of NSCs followed by a 7-day course of 5-FC in recurrent high-grade glioma patients was safe and feasible. With intracerebral microdialysis, the investigators reported that they documented proof-of-concept-that the NSCs convert the prodrug 5-FC to its active metabolite 5-FU in the brain. It was reported that results of immunologic correlative studies showed no evidence of NSC immunogenicity after first exposure. Autopsy data provided evidence that NSCs migrated to distant tumor sites and did not divide and form secondary tumors. The investigators propose that the next step in the clinical development of this new treatment strategy for gliomas is to perform a Phase 1 trial to assess the feasibility of intracranially administering repeat doses of these allogeneic NSCs while continuing to dose escalate to determine the Phase 2 recommended doses of study treatment. Leucovorin, which enhances the efficacy of 5-FU and can cross the blood-brain barrier, will be added to the treatment regimen once the MTD for the combination of NSCs and 5-FC has been identified. The investigators will continue to monitor patients for possible development of immune reactivity against NSCs, study the distribution NSCs on MRI by iron-labeling the NSCs, and measure NSC conversion of 5-FC to 5-FU via intracerebral microdialysis at the MTD of study treatment. In anticipation of performing larger efficacy studies of this treatment strategy at multiple cancer centers, this proposed single center Phase 1 study will assess the feasibility of recently optimized NSC manufacturing and final preparation standard operating procedures. The investigators propose that establishing a simplified process for final NSC preparation before administering to a patient will enable the NSCs to be distributed and easily used at other treatment sites in future multi-center NSC trials.
描述(由申请人提供): 经修饰以表达治疗性转基因的人神经干细胞(NSC)可能有望用于脑肿瘤治疗,这是由于其固有的肿瘤嗜性特性和作为用于将化疗直接递送至脑中的浸润性胶质瘤细胞的载体的潜在用途。神经干细胞可以克服药物递送的障碍,这些障碍限制了目前的基因治疗策略,以提供有效的抗肿瘤反应。 来自动物模型的数据已经证明了NSC用于追踪侵袭性肿瘤细胞以及远端微肿瘤病灶并向肿瘤细胞递送治疗性基因产物的安全性和有效性。研究人员最近完成了一项首次在人体内进行的胞嘧啶脱氨酶(CD)表达的神经干细胞与口服5-氟胞嘧啶(5-FC)联合给药的初步研究,证明了一剂神经干细胞随后7天疗程的5-FC在复发性高级别胶质瘤患者中是安全可行的。通过脑内微透析,研究人员报告说,他们记录了概念验证-NSC在大脑中将前药5-FC转化为其活性代谢物5-FU。据报道,免疫学相关研究结果显示,首次暴露后无NSC免疫原性的证据。尸检数据提供的证据表明,神经干细胞迁移到远处的肿瘤部位,并没有分裂和形成继发性肿瘤。 研究人员建议,这种新的神经胶质瘤治疗策略的临床开发的下一步是进行1期试验,以评估颅内重复给予这些同种异体神经干细胞的可行性,同时继续剂量递增,以确定2期推荐的研究治疗剂量。一旦确定了NSC和5-FC联合治疗的MTD,将在治疗方案中添加可增强5-FU疗效并可穿过血脑屏障的甲酰四氢叶酸。研究者将继续监测患者是否可能发生针对NSC的免疫反应,通过铁标记NSC研究NSC在MRI上的分布,并在研究治疗的MTD下通过脑内微透析测量NSC将5-FC转化为5-FU。 预期在多种癌症中对这种治疗策略进行更大规模的疗效研究 中心,这项拟议的单中心I期研究将评估最近优化的NSC生产和最终制备标准操作规程的可行性。研究人员建议,在给予患者之前建立一个简化的最终NSC制备过程,将使NSC能够在未来的多中心NSC试验中在其他治疗地点分发和轻松使用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karen S Aboody其他文献

Karen S Aboody的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karen S Aboody', 18)}}的其他基金

Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
用于卵巢癌靶向治疗的干细胞/纳米颗粒构建体
  • 批准号:
    9303321
  • 财政年份:
    2015
  • 资助金额:
    $ 20万
  • 项目类别:
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
颅内给予表达羧酸酯酶的神经干细胞联合静脉注射伊立替康治疗复发性高级别胶质瘤患者的 I 期研究
  • 批准号:
    9336834
  • 财政年份:
    2015
  • 资助金额:
    $ 20万
  • 项目类别:
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
用于卵巢癌靶向治疗的干细胞/纳米颗粒构建体
  • 批准号:
    9070755
  • 财政年份:
    2015
  • 资助金额:
    $ 20万
  • 项目类别:
Phase 1 Study of Neural Stem Cells & 5-FC/Leucovorin for the Treatment of Recurrent High Grade Gliomas
神经干细胞的一期研究
  • 批准号:
    8896311
  • 财政年份:
    2014
  • 资助金额:
    $ 20万
  • 项目类别:
Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma
神经干细胞介导的 CE-CPT11 治疗神经母细胞瘤
  • 批准号:
    8911385
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma
神经干细胞介导的 CE-CPT11 治疗神经母细胞瘤
  • 批准号:
    8484289
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma
神经干细胞介导的 CE-CPT11 治疗神经母细胞瘤
  • 批准号:
    9327077
  • 财政年份:
    2013
  • 资助金额:
    $ 20万
  • 项目类别:
A Pilot Study of 5-FC and Genetically-Modified Neural Stem Cells to Treat Gliomas
5-FC 和转基因神经干细胞治疗神经胶质瘤的初步研究
  • 批准号:
    7737841
  • 财政年份:
    2009
  • 资助金额:
    $ 20万
  • 项目类别:
Neural Progenitor Cells as Cancer Therapy Vectors
神经祖细胞作为癌症治疗载体
  • 批准号:
    7913870
  • 财政年份:
    2009
  • 资助金额:
    $ 20万
  • 项目类别:
Neural Progenitor Cells as Cancer Therapy Vectors
神经祖细胞作为癌症治疗载体
  • 批准号:
    7432456
  • 财政年份:
    2005
  • 资助金额:
    $ 20万
  • 项目类别:

相似国自然基金

相似海外基金

An electroencephalography study of the neural correlates of visual habituation in infants with hearing loss
听力损失婴儿视觉习惯神经相关性的脑电图研究
  • 批准号:
    ES/X001946/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Research Grant
Comparative Study of Finite Element and Neural Network Discretizations for Partial Differential Equations
偏微分方程有限元与神经网络离散化的比较研究
  • 批准号:
    2424305
  • 财政年份:
    2024
  • 资助金额:
    $ 20万
  • 项目类别:
    Continuing Grant
Study on the regulation mechanism of neural spine morphology and cognitive function by twinfilin-1
twinfilin-1对神经棘形态和认知功能调节机制的研究
  • 批准号:
    23H02669
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Study for the neural mechanism that synchronizes mating behavior and ovulation
交配行为与排卵同步的神经机制研究
  • 批准号:
    23K14064
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Feasibility Study with Edinburgh Innovations: Scaling Solutions for Neural Network Training with Artist IP Protection
与爱丁堡创新公司进行可行性研究:通过艺术家知识产权保护扩展神经网络训练解决方案
  • 批准号:
    10080229
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Collaborative R&D
Translational approaches to study neural networks in migraine and sleep
研究偏头痛和睡眠神经网络的转化方法
  • 批准号:
    2886689
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Studentship
A study of the mechanism of sensory hyper-responsiveness from the perspective of predictive coding and neural inhibitory dysfunction in autism spectrum disorder
从预测编码和神经抑制功能障碍角度研究自闭症谱系障碍感觉高反应机制
  • 批准号:
    23K03017
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on psychophysical, neural, and social acceptance of augmented body
增强身体的心理物理、神经和社会接受度研究
  • 批准号:
    23K17460
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Does exercise enhance executive function in young children?: Neuroimaging study focusing on the curiosity-linked neural pathways
运动是否能增强幼儿的执行功能?:神经影像学研究重点关注与好奇心相关的神经通路
  • 批准号:
    23KJ1169
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Linking neural mechanisms of emotion and attention with naturalistic trauma symptom experience: An event-related potential and ecological momentary assessment study
将情绪和注意力的神经机制与自然创伤症状体验联系起来:事件相关电位和生态瞬时评估研究
  • 批准号:
    10679288
  • 财政年份:
    2023
  • 资助金额:
    $ 20万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了